27
Views
33
CrossRef citations to date
0
Altmetric
Original Article

Case Fatality of Meningococcal Disease in Western Norway

, , , &
Pages 35-42 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Bjørn G. Iversen & Preben Aavitsland. (1996) Meningococcal Disease in Norway 1992–1995. Epidemiology and Fatality. Scandinavian Journal of Infectious Diseases 28:3, pages 253-259.
Read now
Regina L. Schildkamp, Mariette C. Lodder, Henk A. Bijlmer, Jacob Dankert & Rob J. P. M. Scholten. (1996) Clinical Manifestations and Course of Meningococcal Disease in 562 Patients. Scandinavian Journal of Infectious Diseases 28:1, pages 47-51.
Read now
Stefan Berg, Birger Trollfors, Kjell Alestig & Ulf Jodal. (1992) Incidence, Serogroups and Case-Fatality Rate of Invasive Meningococcal Infections in a Swedish Region 1975–1989. Scandinavian Journal of Infectious Diseases 24:3, pages 333-338.
Read now
K. E. Choo, W. A. Ariffin, T. Ahmad, W. L. Lim & A. K. Gururaj. (1990) Pyogenic meningitis in hospitalized children in Kelantan, Malaysia. Annals of Tropical Paediatrics 10:1, pages 89-98.
Read now
Bjørg Marit Andersen. (1989) Endotoxin Release from Neisseria Meningitidis: Relationship between Key Bacterial Characteristics and Meningococcal Disease. Scandinavian Journal of Infectious Diseases 21:sup64, pages 1-43.
Read now
Alfred Halstensen, Haakon Sjursen, Stein E. Vollset, L. Oddvar Frøholm, Are Næss, Roald Matre & Claus Ola Solberg. (1989) Serum Opsonins to Serogroup B Meningococci in Meningococcal Disease. Scandinavian Journal of Infectious Diseases 21:3, pages 267-276.
Read now

Articles from other publishers (27)

Rishikesh Rijal, Kamal Kandel, Barun Babu Aryal, Ankush Asija, Dhan Bahadur Shrestha & Yub Raj Sedhai. 2023.
Berit Sletbakk Brusletto, Else Marit Løberg, Bernt Christian Hellerud, Ingeborg Løstegaard Goverud, Jens Petter Berg, Ole Kristoffer Olstad, Unni Gopinathan, Petter Brandtzaeg & Reidun Øvstebø. (2020) Extensive Changes in Transcriptomic “Fingerprints” and Immunological Cells in the Large Organs of Patients Dying of Acute Septic Shock and Multiple Organ Failure Caused by Neisseria meningitidis. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Constance M. John, Nancy J. Phillips, Daniel C. Stein & Gary A. Jarvis. (2017) Innate immune response to lipooligosaccharide: pivotal regulator of the pathobiology of invasive Neisseria meningitidis infections. Pathogens and Disease 75:3.
Crossref
Navin P. Boeddha, Gertjan J. Driessen, Marjon H. Cnossen, Jan A. Hazelzet & Marieke Emonts. (2016) Circadian Variation of Plasminogen-Activator-Inhibitor-1 Levels in Children with Meningococcal Sepsis. PLOS ONE 11:11, pages e0167004.
Crossref
David S. Stephens & Michael A. Apicella. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 2425 2445.e6 .
Michael J. Goldacre & Jenny J. Maisonneuve. (2013) Mortality from meningococcal disease by day of the week: English national linked database study. Journal of Public Health 35:3, pages 413-421.
Crossref
Petter Brandtzaeg & Marcel van Deuren. 2012. Neisseria meningitidis. Neisseria meningitidis 21 35 .
Michael PfallerAlasdair Geddes & Ian Gould. 2010. Kucers' The Use of Antibiotics Sixth Edition. Kucers' The Use of Antibiotics Sixth Edition 5 58 .
S. C. Greeff, H. E. Melker, L. M. Schouls, L. Spanjaard & M. Deuren. (2008) Pre-admission clinical course of meningococcal disease and opportunities for the earlier start of appropriate intervention: a prospective epidemiological study on 752 patients in the Netherlands, 2003–2005. European Journal of Clinical Microbiology & Infectious Diseases 27:10, pages 985-992.
Crossref
I. SMITH, A. T. BJØRNEVIK, I. M. B. AUGLAND, A. BERSTAD, T. WENTZEL-LARSEN & A. HALSTENSEN. (2005) Variations in case fatality and fatality risk factors of meningococcal disease in Western Norway, 1985–2002. Epidemiology and Infection 134:1, pages 103-110.
Crossref
Luis Jódar, Ian M Feavers, David Salisbury & Dan M Granoff. (2002) Development of vaccines against meningococcal disease. The Lancet 359:9316, pages 1499-1508.
Crossref
Marcel van Deuren, Petter Brandtzaeg & Jos W. M. van der Meer. (2000) Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management. Clinical Microbiology Reviews 13:1, pages 144-166.
Crossref
Gregory R. Moe, Siqi Tan & Dan M. Granoff. (1999) Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease . FEMS Immunology & Medical Microbiology 26:3-4, pages 209-226.
Crossref
M. Van Deuren, J. W. M. Van der Meer, C. Neeleman & L. G. F. M. Van ’t Hek. (1998) A normal platelet count at admission in acute meningococcal disease does not exclude a fulminant course. Intensive Care Medicine 24:2, pages 157-161.
Crossref
Marcel van DeurenJohanna van der Ven-JongekrijgEdouard VannierRoelof van DalenGerard PesmanAnton K.M. BartelinkCharles A. DinarelloJos W.M. van der Meer. (1997) The Pattern of Interleukin-1β (IL-1β) and Its Modulating Agents IL-1 Receptor Antagonist and IL-1 Soluble Receptor Type II in Acute Meningococcal Infections. Blood 90:3, pages 1101-1108.
Crossref
Marcel van DeurenJohanna van der Ven-JongekrijgEdouard VannierRoelof van DalenGerard PesmanAnton K.M. BartelinkCharles A. DinarelloJos W.M. van der Meer. (1997) The Pattern of Interleukin-1β (IL-1β) and Its Modulating Agents IL-1 Receptor Antagonist and IL-1 Soluble Receptor Type II in Acute Meningococcal Infections. Blood 90:3, pages 1101-1108.
Crossref
Silvana Granado N. Gama, Keyla B. Feldman Marzochi & Getúlio Borges da Siveira Filho. (1997) Caracterização epidemiológica da doença meningocócica na área metropolitana do Rio de Janeiro, Brasil, 1976 a 1994. Revista de Saúde Pública 31:3, pages 254-262.
Crossref
Johan T. M. Frieling, Marcel van Deuren, John Wijdenes, Roelof van Dalen, Anton K. M. Bartelink, Cees J. van der Linden & Robert W. Sauerwein. (1996) Interleukin-6 and its soluble receptor during acute meningococcal infections. Critical Care Medicine 24:11, pages 1801-1805.
Crossref
P. Kriz, J. Vlckova & M. Bobak. (2009) Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic. Epidemiology and Infection 115:3, pages 411-418.
Crossref
T Flaegstad, PI Kaaresen, T Stoklando & T Gutteberg. (2008) Factors associated with fatal outcome in childhood meningococcal disease. Acta Paediatrica 84:10, pages 1137-1142.
Crossref
N. Brassier, A. Lepoutre, M. Guibourdenche, C. Moyse & J.Y. Riou. (1995) Meningococcal meningitis and meningococcemia : epidemiological study, France (1985–1991). Médecine et Maladies Infectieuses 25:4, pages 584-592.
Crossref
A. Naess, A. Halstensen, H. Nyland, S.H.J. Pedersen, P. Møller, R. Borgmann, J. L. Larsen & E. Haga. (2009) Sequelae one year after meningococcal disease. Acta Neurologica Scandinavica 89:2, pages 139-142.
Crossref
R. J. P. M. Scholten, H. A. Bijlmer, H. A. Valkenburg & J. Dankert. (2009) Patient and strain characteristics in relation to the outcome of meningococcal disease: a multivariate analysis. Epidemiology and Infection 112:1, pages 115-124.
Crossref
M van Deuren, B J van Dijke, R J Koopman, A M Horrevorts, J F Meis, F W Santman & J W van der Meer. (1993) Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions.. BMJ 306:6887, pages 1229-1232.
Crossref
Petter Brandtzaeg, Alfred Halstensen, Peter Kierulf, Terje Espevik & Anders Waage. (1992) Molecular mechanisms in the compartmentalized inflammatory response presenting as meningococcal meningitis or septic shock. Microbial Pathogenesis 13:6, pages 423-431.
Crossref
S.R. Palmer, J. Corson, R. Hall, S. Payne, J. Ludlow, B. Deere, H. Jones, S. Kaul, J. Stubbins, R. Williams, M. Walapu, A. Spence, P. Jenkins & D. Donald. (1992) Meningococcal disease in Wales: Clinical features, outcome and public health management. Journal of Infection 25:3, pages 321-328.
Crossref
B E KristiansenP RådströmA JenkinsE AskB FacinelliO Sköld. (1990) Cloning and characterization of a DNA fragment that confers sulfonamide resistance in a serogroup B, serotype 15 strain of Neisseria meningitidis. Antimicrobial Agents and Chemotherapy 34:11, pages 2277-2279.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.